Dolutegravir

Details

Files

Generic Name:

Dolutegravir

Project Status:

Complete

Therapeutic Area:

HIV infection

Manufacturer:

ViiV Healthcare ULC

Call for patient/clinician input open:

September 26, 2013

Brand Name:

Tivicay

Project Line:

Reimbursement Review

Project Number:

SR0357-000

Call for patient/clinician input closed:

November 8, 2013

NOC Status at Filing:

Pre NOC

Submission Type:

Initial

Indications:

HIV infection

Recommendation Type:

List

Final Recommendation:

August 18, 2014

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Last Updated : October 18, 2013